DEC 04, 2019 8:01 AM PST

Genetic platform takes the guesswork out of catching infections

WRITTEN BY: Tara Fernandes

A physician is faced with 3 patients: an elderly person with a chronic cough, a child being wheeled out of surgery and a young mother with a high fever. How does the doctor identify which of these patients needs antibiotics? The answer: mostly guesswork. And, more than likely, all 3 will be prescribed with a course of antibiotics.

The problem, as described by physician turned entrepreneur Tim Sweeney, lies in the fact that we don’t have a way of accurately detecting the early stages of bacterial or viral infections. While hospitals routinely use blood tests, the majority of pathogenic infections are, in fact, not detectable in the blood circulation. To play it safe, physicians often administer antibiotics as a precautionary measure, especially considering the drug-free alternative could mean an elevated risk of sepsis.

During sepsis, an extreme inflammatory response floods the body with chemicals to fight the infection. This process can snowball, triggering dangerous and potentially life-threatening chemical imbalances, culminating in irreversible damage to multiple organ systems. Sepsis represents a major clinical crisis, responsible for half of all deaths in hospital and is the most expensive diagnosis in the US healthcare system.

The unconstrained use of antibiotics, however, is not the answer. Not only do these drugs pose significant side effects to patients, but they also contribute to a serious global epidemic: the steady rise of the antibiotic-resistant superbug.

Sweeney, together with a team of computational immunologists at Stanford University envisioned a future where doctors had access to robust diagnostic tools to check for the early signs of infections, leaving the guesswork out of the equation. 

Using machine learning methods, they analyzed the genetic activation signatures of multiple cohorts of patients around the world. This technique, called transcriptomic analysis, enabled them to draw out definitive patterns of activation in genes that control inflammation, in patients with bacterial and viral infections. 

Fascinatingly, the team discovered specific genetic motifs unique to patients at risk of sepsis. Analyzing a cluster of just 7 genes gave the researchers enough information on the presence and severity of the infection, even highlighting whether it is bacterial or viral in nature.

Expanding this to a set of 30 genes increased the granularity of the diagnosis, including what type of treatment would be most effective, downstream diagnostic tests to run and whether or not the individual needs urgent emergency care. All this in under 30 minutes.

This innovation has been commercialized by the start-up company Inflammatix, of which Sweeny is a co-founder. Inflammatix has been creating a buzz recently after getting a $6 million funding injection from the Biomedical Advanced Research and Development Authority (BARDA) to further develop its platform for diagnosing both sepsis and influenza. 

If all goes well, the deal has the potential to be worth up to $72 million - a relatively small price for the lifesaving potential of this technology.


Sources: Inflammatix, TEDx Talks

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
JUN 14, 2022
Coronavirus
Advances in Latest Coronavirus Research in the 2022 Ongoing Labroots Virtual Event Series
JUN 14, 2022
Advances in Latest Coronavirus Research in the 2022 Ongoing Labroots Virtual Event Series
Labroots hosted its 3rd annual Coronavirus Conference Virtual Event Series on May 4, 2022. The speaker roster for this f ...
JUN 20, 2022
Cancer
Uterine Cancer Mortality is on the Rise
JUN 20, 2022
Uterine Cancer Mortality is on the Rise
Uterine cancer develops when cells in the inner lining of the uterus, known as the endometrium, undergo uncontrolled and ...
JUN 21, 2022
Clinical & Molecular DX
Childhood Bronchitis Linked to Pneumonia and Lung Issues in Adulthood
JUN 21, 2022
Childhood Bronchitis Linked to Pneumonia and Lung Issues in Adulthood
Over 50 years ago, researchers began gathering data for the Tasmanian Longitudinal Health Study (TAHS). The TAHS, which ...
JUL 11, 2022
Neuroscience
Chronic Stress Reduces Iron Absorption in Newborns by 15%
JUL 11, 2022
Chronic Stress Reduces Iron Absorption in Newborns by 15%
Chronic stress in the last months of pregnancy can reduce a growing fetus’s ability to absorb iron by up to 15%. T ...
JUL 26, 2022
Clinical & Molecular DX
Researchers Recognize New Complicating Factor in Organ Transplantation
JUL 26, 2022
Researchers Recognize New Complicating Factor in Organ Transplantation
Organ transplantation is a life-saving measure that is often a last resort to treat end-stage organ failure. Organ trans ...
JUL 25, 2022
Cardiology
Drug that Can Help Men Live Longer?
JUL 25, 2022
Drug that Can Help Men Live Longer?
A new study from the University of Virginia School of Medicine and recently published in Science discusses how the loss ...
Loading Comments...